Search clinical trials for: Bortezomib-bendamustine-melphalan
Total 1966 results
-
Uppsala UniversityDalarna County Council, Sweden; Uppsala County Council, SwedenNot yet recruitingMyeloma Multiple
-
CephalonCompletedMultiple MyelomaUnited States
-
University Hospital HeidelbergGerman Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... and other collaboratorsCompleted
-
NYU Langone HealthCephalonTerminated
-
Fondazione EMN Italy OnlusCompleted
-
University Hospital, ToulouseMinistry of Health, France; Janssen, LPCompletedMultiple MyelomaFrance, Belgium
-
Dartmouth-Hitchcock Medical CenterMillennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaUnited States
-
University of California, San FranciscoTerminatedMultiple Myeloma | Patient ParticipationUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedWaldenstrom's MacroglobulinemiaItaly
-
University of California, San FranciscoWithdrawn
-
Peter MoosmannKantonsspital AarauCompletedLymphoma, Non-Hodgkin
-
Gustave Roussy, Cancer Campus, Grand ParisTerminatedSTAGE IIIB OR IV NON-SMALL CELL LUNG CANCERFrance
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University Hospital TuebingenArbeitsgemeinschaft fur Internistische Onkologie; German Sarcoma GroupCompleted
-
University Hospital Inselspital, BerneMundipharma Medical CompanyCompleted
-
Weill Medical College of Cornell UniversityCompletedMultiple MyelomaUnited States
-
Charite University, Berlin, Germanyribosepharm GmbHUnknownRecurrent Small Cell Lung CancerGermany
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Untreated Adult Acute Myeloid... and other conditionsUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
Rehab WeridaCompleted
-
Intergroupe Francophone du MyelomeCompleted
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Janssen-Ortho Inc., CanadaOrtho Biotech CanadaNo longer available
-
Austrian Forum Against CancerCompletedMultiple MyelomaAustria, Czech Republic
-
Medical University of ViennaRecruitingMantle-cell LymphomaAustria
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.Terminated
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
Beth ChristianCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Meir Medical CenterAssuta Ashdod Hospital; Rabin Medical Center; Tel-Aviv Sourasky Medical Center; Ziv Medical CenterRecruiting
-
Peking UniversityAvailable
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
University of ArizonaCephalonCompletedOvarian CancerUnited States
-
The First Affiliated Hospital of Soochow UniversityUnknownMultiple Myeloma Proved by Laboratory TestsChina